Biostax (BTAX) Financial Statements

11 Followers

Biostax Financial Overview

Biostax's market cap is currently $7.87K. The company's EPS TTM is $0; its P/E ratio is >-0.01; Biostax is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -1.48M	$ -1.16M	$ -887.03K
EBITDA	$ -2.14M	$ -3.42M	$ 2.07M
Net Income	$ -2.36M	$ -3.54M	$ 1.59M
Balance Sheet
Cash & Short-Term Investments	$ 29.79K	$ 150.49K	$ 9.97K
Total Assets	$ 35.28K	$ 963.72K	$ 10.17K
Total Debt	$ 1.13M	$ 696.48K	$ 2.84M
Net Debt	$ 1.10M	$ 545.99K	$ 2.83M
Total Liabilities	$ 4.56M	$ 3.48M	$ 11.68M
Stockholders' Equity	$ -4.53M	$ -2.51M	$ -11.67M
Cash Flow
Free Cash Flow	$ -408.03K	$ -1.08M	$ -191.96K
Operating Cash Flow	$ -408.03K	$ -581.82K	$ -191.96K
Investing Cash Flow	$ 0.00	$ -500.00K	$ 0.00
Financing Cash Flow	$ 287.32K	$ 738.43K	$ 197.00K

Currency in USD

Biostax Earnings and Revenue History

Income Statement >

Biostax Debt to Assets

Balance Sheet >

Biostax Cash Flow

Cash Flow >

Biostax Forecast EPS vs Actual EPS

Earnings >